Impact of Candida Species on Clinical Outcomes in Patients with Suspected Ventilator-Associated Pneumonia

Affiliations

Marie-Soleil Delisle: Department of Pharmacy Services, The Montreal General Hospital, Canada
David R Williamson: Department of Pharmacy Services, Hôpital du Sacré-Cœur de Montréal, Faculté de Pharmacie, Université de Montréal, Canada
Martin Albert: Departments of Critical Care and Internal Medicine, Hôpital du Sacré-Cœur de Montréal, Faculté de Médecine, Université de Montréal, Canada
Marc M Perreault: Department of Pharmacy Services, The Montreal General Hospital and Faculté de Pharmacie, Université de Montréal, Montréal, Quebec, Canada
Xuran Jiang: Clinical Evaluation Research Unit, Kingston General Hospital, Canada
Andrew G Day: Clinical Evaluation Research Unit, Kingston General Hospital, Canada
Daren K Heyland: Clinical Evaluation Research Unit, Kingston General Hospital, Canada

Abstract

BACKGROUND: The significance of Candida species in respiratory tract (RT) secretions in critically ill patients is unclear.

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503